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Abstract: The aggregation and accumulation of amyloidβ (Aβ) in the brain is a trigger of pathogenesis
for Alzheimer’s disease. Previously, we developed a microliter-scale high-throughput screening
(MSHTS) system for Aβ42 aggregation inhibitors using quantum-dot nanoprobes. The MSHTS
system is seldom influenced by contaminants in samples and is able to directly evaluate Aβ42
aggregation inhibitory activity of samples containing various compounds. In this study, to elucidate
whether the MSHTS system could be applied to the evaluation of processed foods, we examined
Aβ42 aggregation inhibitory activity of salad dressings, including soy sauces. We estimated the 50%
effective concentration (EC50) from serial diluted dressings. Interestingly, all 19 commercial dressings
tested showed Aβ42 aggregation inhibitory activity. It was suggested that EC50 differed by as much
as 100 times between the dressings with the most (0.065 ± 0.020 v/v%) and least (6.737 ± 5.054 v/v%)
inhibitory activity. The highest activity sample is traditional Japanese dressing, soy sauce. It is
known that soy sauce is roughly classified into a heat-treated variety and a non-heat-treated variety.
We demonstrated that non-heat-treated raw soy sauce exhibited higher Aβ42 aggregation inhibitory
activity than heat-treated soy sauce. Herein, we propose that MSHTS system can be applied to
processed foods.
Keywords: Alzheimer’s disease; Amyloidβ; amyloidβ aggregation inhibitor; quantum dot; soy sauce
1. Introduction
One of the problems facing an aging society is the increase of patients with dementia. While various
diseases are known to cause dementia, Alzheimer’s disease (AD) in particular, accounts for the
majority of cases [1–3]. Four AD drugs approved in Japan, donepezil, galantamine, rivastigmine,
and memantine, only function by delaying the progression of pathological conditions by temporarily
enhancing neurotransmission, and are not fundamental therapeutic agents [4]. The amyloid cascade
hypothesis notes that AD is caused by the aggregation and accumulation of 38 to 43 residues of the
amyloidβ (Aβ) peptide excised from amyloid precursor protein in the brain [5–8]. Recently, Biogen and
Eisai reported that a patient’s cognitive decline had been blunted in clinical trials using antibodies,
aducanumab, that bind specifically to Aβ aggregates [9]. However, in March of 2019, a phase III
clinical trial of aducanumab was halted because of insufficient evidence to support its effect in AD [10].
In October of 2019, both companies announced that they would apply for a new drug application of
aducanumab to the U.S. Food and Drug Administration in 2020, as the effect was confirmed in some
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patients who received the drug at a high dose. However, these events remind us of the difficulties in
developing AD therapeutics. Therefore, attention is now focused on AD prevention and treatment
schemes that target the aggregation and accumulation of Aβ. There is currently a global search for
candidate substances that can inhibit Aβ aggregation. Since the aggregation and accumulation of Aβ
begins several decades before the expression of AD [11], long-term prevention with functional foods
may be more effective than treatment with therapeutic medicine.
Rosmarinic acid (RA) is a polyphenol found in abundance in plants of the Lamiaceae such as
rosemary, perilla, and lemon balm. RA is a known inhibitor of Aβ aggregation [12,13]. Its Aβ
aggregation inhibitory activity was examined using AD model mice and its safety was confirmed
in human studies using lemon balm extract [14,15]. Among many other polyphenols, curcumin,
which is found in turmeric, is also a famous Aβ aggregation inhibitor [12]. Further, it was reported
that importance of functional foods on AD. The extract obtained from miso, a traditional fermented
dressing in Japan, suppresses Aβ-induced neuronal damage [16]. Hsu et al., reported that nattokinase
degraded amyloid fibrils [17]. Thus, the use of functional foods has attracted attention as a possible
AD countermeasure. However, it is technically very difficult to evaluate plant extracts and processed
foods as these include various impurities. In general, the Thioflavin T (ThT) method has been used
to evaluate Aβ aggregation inhibitory activity of various substances [18]. ThT emits fluorescence
when bound to amyloid fibrils. In this method, the level of Aβ aggregation is measured from the
fluorescence intensity of ThT. However, the excitation and emission wavelengths of ThT are 455 and
490 nm, respectively, so they compete with the absorption wavelengths of many natural substances.
Therefore, the ThT method is unsuitable to evaluate food samples that contain various contaminants.
A method of directly observing Aβ aggregates with a transmission electron microscope (TEM) is widely
used. Because it is necessary to dry the Aβ aggregates sample when preparing, the observation under
physiological conditions is difficult. Further, the amount of aggregates is biased depending on the field
of view even in the same sample, suggesting that there is a problem in quantitative. In addition, the ThT
and TEM method generally require several steps for sample preparation and observation, and it is
difficult to analyze a large amount of the sample at one time. In other words, previous conventional
method could not perform accurate and quick high throughput quantitative analysis.
Previously, we succeeded in real-time imaging of the Aβ42 aggregation process with a fluorescence
microscope using a quantum dot (QD) nanoprobe and developed a microliter-scale high-throughput
screening (MSHTS) system for Aβ42 aggregation inhibitors by applying this imaging method [19,20].
The MSHTS system has some advantages: (1) only a small sample volume of 5 µL is required,
(2) high-throughput analysis uses a 1536-well plate, and (3) filter effects due to contaminants in the
sample are avoided because the amount of Aβ42 aggregates is quantified from standard deviation (SD)
value estimated from the variation in fluorescence intensity of each pixel of obtained images and the
emission wavelength of QD605 does not overlap with the absorption of almost natural products [20,21].
Thus, the MSHTS system can evaluate the magnitude of inhibitory activity for Aβ42 aggregation as
EC50 values. Before, we evaluated the Aβ42 aggregation inhibitory activity of 52 spices using this
method and demonstrated that the herb-based spices of the Lamiaceae family exhibited high Aβ42
aggregation inhibitory activity [20]. Then, we found that the activity of boiling water extracts of 11
seaweeds was higher than that of ethanolic extracts and revealed that Aβ42 aggregates morphology
was affected with seaweed-derived polysaccharide including in boiling water extracts [22]. Further,
we recently developed an automated MSHTS system to evaluate larger numbers of samples at once [21].
Screening 504 plant extracts collected in Hokkaido, Japan, we found that Geraniales and Myrtales
within Rosids showed high Aβ42 aggregation inhibitory activity. Thus, MSHTS system is useful for
quantitative evaluation of Aβ42 aggregation inhibition ability of various natural products. However, it is
unclear whether MSHTS system can evaluate Aβ42 aggregation inhibitory activity in foods including
various natural substances with many impurities. In this study, to elucidate whether the MSHTS
system is applied to processed foods such as salad dressings, including soy sauces, we evaluated
Aβ42 aggregation inhibitory activity of dressings using the MSHTS system. We found that all tested
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commercial dressings showed Aβ42 aggregation inhibitory activity despite there were differences in
their activities. Especially raw soy sauce showed the highest inhibitory activity among the tested
samples. These results suggest that the MSHTS system is a powerful and useful tool that is expected to
be applied and developed in various processed foods.
2. Materials and Methods
2.1. Materials
Human Aβ42 (4349-v, Peptide Institute Inc., Osaka, Japan) and Cys-conjugated Aβ40 (23519,
Anaspec Inc., Fremont, CA, USA) kits were purchased commercially. Twenty different commercially
available salad dressings and soy source brands were purchased from Japanese companies
(Kewpie, Sameura Foods, Sanyo Coffee Foods, Shiranukacho Shinko Kosha, Shinshu Shizen Okoku,
Seijo Ishii, Taiyo Sangyo, Tsukiboshi Foods, Nihon Syoyu Kogyo, Big Chef, Pure Foods Toya, Yamada
Bee Farm, Riken Vitamin, H+B Life Science) using catalog shopping in June 2016.
2.2. Preparation of QDAβ Nanoprobe
The QDAβ nanoprobe was prepared using QD-PEG-NH2 (QdotTM 605 ITKTM Amino (PEG)
Quantum dot; Q21501MP, Thermo Fisher Scientific, Waltham, MA USA) according to our previous
reports [19–22]. The QDAβ nanoprobe was prepared by first reacting 10 µM QD-PEG-NH2 with 1 mM
sulfo-EMCS (22307, Thermo Fisher Scientific, Waltham, MA, USA) in PBS (phosphate-buffered saline)
for 1 h at room temperature. QDAβ concentration was determined by comparing absorbance at 350 nm
to that of unlabeled QD-PEG-NH2.
2.3. Estimation of EC50 by the MSHTS System
The EC50 values of various dressings were determined by a modified MSHTS system, as was
described in our previous reports [20–22]. More specifically, various concentrations of each dressing,
30 nM QDAβ, and 30 µM Aβ42 in PBS containing 5% EtOH and 3% DMSO were incubated in a 1536-well
plate (782096, Greiner, Kremsmünster, Austria) at 37 ◦C for 24 h. The QDAβ-Aβ42 aggregates that formed
in each well were observed by an inverted fluorescence microscope (TE2000, Nikon, Tokyo, Japan).
Standard deviation (SD) values of fluorescence intensities of 40,000 pixels (200 × 200 pixels) around
the central region of each well were measured by ImageJ software Ver 1.53b (NIH). The SD values,
which were approximately proportional to the amount of aggregates [20–22], were plotted against the
concentrations of added salad dressings to establish an inhibition curve.
2.4. Fluorescence Microscopy
Aggregates in the 1536-well plate were observed by an inverted fluorescence microscope
(TE2000-S, Nikon) using a 4× objective lens (Plan Fluor 4×/0.13 PhL DL, Nikon) equipped with
a color CCD camera (DP72, Olympus, Tokyo, Japan).
2.5. Transmission Electron Microscopy
Samples were deposited in 10 µL aliquots onto 200-mesh copper grids and negatively stained
with 1% phosphotungstic acid at room temperature. Specimens were examined under an H-7600 TEM
(Hitachi, Tokyo, Japan) at 60 kV.
2.6. ThT Assay
The ThT assay was conducted according to the method of Levine modified in our laboratory [18,21].
Statistical analyses between +ThT and −ThT samples were performed with EZR (Saitama Medical
Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R
Foundation for Statistical Computing) [23]. More precisely, it is a modified version of R commander
designed to add statistical functions frequently used in biostatistics.
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2.7. SDS-Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed using standard techniques.
Soy sauce and raw soy sauce were heated by block incubator at 80 ◦C for 60 min before
electrophorese. For dialysis protocol, soy sauce and raw soy sauce were dialyzed against distilled
water. Distilled were changed three times for overnight. Then, the gel was silver-stained by staining kit
(2D-SLVER STAIN II, COSMO BIO)
3. Results and Discussion
3.1. Evaluation of Aβ42 Aggregation Inhibitory Activity of Commercial Dressings by ThT Method
First, in order to assess whether 19 liquid salad dressings could be evaluated for activity by the ThT
method, their absorbance spectra were measured using a Nanodrop 2000c (Thermo Fisher Scientific)
(Figure 1). The excitation and emission wavelengths of ThT are 450 nm and 490 nm, respectively.
As shown in Figure 1, only 3 of the 19 dressings (samples L, N, M) showed no absorbance of 1 or more
at each wavelength. Most of the samples contained soy sauce as a raw material, and the color was
black or brown depending on the content of soy sauce. In the 15 samples that showed absorption peaks
at the ThT excitation and emission wavelengths, the absorption peak shifted to the right in proportion
as the color became darker. This indicates that the evaluation of Aβ42 aggregation inhibitory activity of
the liquid dressings using the ThT method was difficult because the absorption wavelength of almost
samples overlapped with the excitation and emission wavelengths of ThT.Foods 2020, 9, x FOR PEER REVIEW 5 of 14 
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ThT solution are mixed with sample; Aβ42 (−), ThT (+): only ThT solution is mixed with sample 
solution; Aβ42 (−), ThT (−): neither Aβ42 solution nor ThT solution are mixed and only the sample 
solution is used. As a negative control, the sample used was an assay buffer (10% EtOH, 1 × PBS) 
under the conditions of Aβ42 (+) and ThT (+) (black line), and its average value of absorbance was 5.28 
(A.U.). There is no significant difference between +ThT (+/− Aβ42) and ThT (−) condition in all samples 
(One way ANOVA, p > 0.05). 
Figure 1. Absorbance of 19 commercial liquid dre gs. Absorbance of the 19 commercial liquid
dressings shown in Table 1 was measured. As for the absorption wavelength of dressings, three samples
(L, M, N) do not show an overlap with the excitation (450 nm) and emission (490 nm) wavelengths of
ThT. Two samples (H, G) overlap with the ThT excitation wavelength. The remaining 14 samples had
an overlap with both excitation and emission wavelengths.
To confirm whether the evaluation using ThT method was performed correctly, the fluorescence
intensity of five samples at a high concentration (40 v/v%) was measured in three conditions;
+Aβ42 and +ThT, −Aβ42 and +ThT, −Aβ42 and −ThT (Figure 2). Soy sauce (sample A), soy sauce
containing perilla (sample B), Japanese style dressing (sample C), oil dressing (sample D), and Chinese
dressing (sample E) were selected and evaluated. Soy sauce (sample A) was used as the control for the
other four samples. At 40 v/v% sample concentration, the fluorescence intensity of the −Aβ42 solution,
−Aβ42 and −ThT solution were not significantly different from that of the solution containing Aβ42
and ThT. We confirmed that samples A and B showed higher fluorescence intensity than only Aβ42
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and ThT sample in all conditions (negative control, black line). The fluorescence intensity of samples
C, D, and E did not show a higher value than the negative control. The color and some components of
the evaluated samples may affect the ThT method by absorbing the excitation or emission of ThT. If the
sample solution without Aβ42 exhibits a higher fluorescence intensity than the negative control, it is
difficult to determine whether the sample solution affects ThT. Therefore, the ThT method might not
accurately evaluate the Aβ42 aggregation inhibitory activity of a commercial dressing.
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Figure 2. Effect of sample solution on ThT fluorescence intensity. Aβ42 (+), ThT (+): Aβ42 solution
and ThT solution are mixed with sample; Aβ42 (−), ThT (+): only ThT solution is mixed with sample
solution; Aβ42 (−), ThT (−): neither Aβ42 solution nor ThT solution are mixed and only the sample
solution is used. As a negative control, the sample used was an assay buffer (10% EtOH, 1 × PBS)
under the conditions of Aβ42 (+) and ThT (+) (black line), and its average value of absorbance was
5.28 (A.U.). There is no signific t difference between +ThT (+/− Aβ42) an ThT (−) condition in all
samples (One way OVA, p > 0.05).
3.2. Evaluation of Aβ42 Aggregation Inhibitory Activity of Commercial Dressings Using MSHTS Sysytem
Previously, we reported the real-time imaging of the Aβ42 aggregation process with a fluorescence
microscope using QD nanoprobes (Figure 3A) and developed MSHTS system (Figure 3B) for Aβ42
aggregation inhibitors by applying this imaging method [19,20]. In the MSHTS system, QD-labeled Aβ
co-aggregated with intact Aβ42, so that amyloid aggregates were observed by fluorescence microscopy.
Since the emission wavelength of QD605 does not overlap with the absorption of almost dressings, it is
less susceptible to substances that exhibit an inner filter effect. These aggregates (complex of Aβ42
and QD Aβ) caused an inhomogeneous distribution of fluorescence intensity in images, resulting in
an increased standard deviation (SD) value estimated from the variation in fluorescence intensity of
each pixel in the images. Therefore, we could estimate the effects of certain aggregation inhibitors
by detecting changes in the SD value. Here, we evaluated the Aβ42 aggregation inhibitory activity
of 19 commercial dressings using the MSHTS system (Figure 3C), and estimated the EC50 values
from the SD value of each image (Table 1). In Table 1, EC50 values are sorted in ascending order of
aggregation inhibitory activity, then each dressing was assigned a letter from A to S. As shown in
Figure 3C, all commercial dressings almost completely inhibited Aβ42 aggregation at a concentration
of 40 v/v%. Samples A to J completely inhibited aggregation even at 4 v/v%, whereas samples K to S
formed small aggregates. At a concentration of 0.4 v/v%, a slight change in the shape of aggregates
was observed in samples A to E. The EC50 value of the sample with the highest activity was 0.065 v/v%,
and that with the lowest activity was 6.737 v/v%. There was an about 100-fold difference in activity
between these 2 samples. Among the 19 dressings, only three samples (D, K, and N) contained plant
oil while the other 16 samples were non-oil type dressings. We compared the mean value of EC50
value of non-oil and oil type (non-oil type: 1.330 ± 1.692 v/v%, oil type: 1.019 ± 0.946 v/v%) and
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performed a statistical analysis. There was no significant difference between non-oil type and oil
type (Student’s t-test, p > 0.05). The activity did not depend on the presence of oil, suggesting that
oil in the dressing did not affect the Aβ42 aggregation inhibitory activity. Next, to confirm whether
Aβ42 aggregation was inhibited by the effect of the dressing, we observed the Aβ42 aggregates at a
sample concentration of 0.04 v/v% using TEM (Figure 4). Sample A, which had high Aβ42 aggregation
inhibitory activity, showed a significant decrease in Aβ42 aggregates compared to samples J and S.
Sample J also significantly decreased aggregates than sample S. These results were consistent with
the Aβ42 aggregation inhibitory activity calculated by the MSHTS system. Sample A, which showed
the highest Aβ42 aggregation inhibitory activity, was soy sauce, a traditional Japanese liquid dressing.
The remaining 17 samples, except for sample D, contained soy sauce. In other words, soy sauce
evidently exhibited high Aβ42 aggregation inhibitory activity. Natto, a traditional Japanese food made
of fermented soybeans, has antibacterial, as well as a soybean peptide with a neuroprotective effect [24].
It is possible that soybean-derived proteins found in soy sauce, and/or various metabolic products
caused by soybean fermentation, may have a positive effect on AD.Foods 2020, 9, x FOR PEER REVIEW 7 of 14 
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Figure 3. Evaluation of Aβ42 aggregation inhibitory activity using the MSHTS system. (A) Real-time
imaging of Aβ42 aggregation using a quantum-dot nanoprobe using fluorescence microscopy. Aβ42 and
QDAβ were mixed and incuba d for 4 h at 37 ◦C. Co-aggregates of Aβ42 and QDAβ formed.
(B) A scheme of the MSHTS system of Aβ42 aggregation inhibitors. (C) Fluorescence microscope image
of concentration-dependent inhibition of Aβ42 aggregation of dressings observed by the MSHTS system.
At a sample conc ntr tion of 4 v/v% or more, the brightness of the image was uniform, indicating that
no Aβ42 aggregates formed. At a sample concentration of 0.04 v/v% or less, Aβ42 aggregates were
observed in all samples. All images were captured using a conventional fluorescence microscope.
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Table 1. EC50 values of 19 commercial dressing samples using MSHTS system.
Sample EC50 (v/v%) Oil Type
RA (positive control) 0.122 ± 0.034 (w/v%) -
A 0.065 ± 0.020 Non-oil
B 0.094 ± 0.017 Non-oil
C 0.133 ± 0.021 Non-oil
D 0.227 ± 0.026 Oil
E 0.230 ± 0.026 Non-oil
F 0.334 ± 0.075 Non-oil
G 0.395 ± 0.130 Non-oil
H 0.413 ± 0.084 Non-oil
I 0.480 ± 0.101 Non-oil
J 0.508 ± 0.025 Non-oil
K 0.763 ± 0.607 Oil
L 1.350 ± 0.247 Non-oil
M 1.360 ± 0.590 Non-oil
N 2.067 ± 0.728 Oil
O 2.132 ± 1.473 Non-oil
P 2.150 ± 0.887 Non-oil
Q 2.313 ± 0.490 Non-oil
R 2.580 ± 0.173 Non-oil
S 6.737 ± 5.054 Non-oil
3.3. Effect of Salt Concentration on Aβ42 Aggregation
In general, it is well known that the soy sauce contains a large amount of NaCl and that high salt
concentration affects protein aggregation. In order to determine whether the Aβ42 aggregation inhibitory
activity of soy sauce was due to NaCl, we examined the effect of NaCl concentration on the shape of
Aβ42 aggregates (Figure 5A). We prepared a 4000 mM NaCl solution. Then, the solution was gradually
diluted to six concentrations with five-fold dilutions. These 7 concentrations of NaCl solution was mixed
with the 50 µM Aβ42 solution and observed using the MSHTS system. The formation of Aβ42 aggregates
was slightly affected by 200 mM NaCl solution. At 1000 mM of NaCl, Aβ42 aggregates were fragmented,
and at 2000 mM, abnormal aggregates such as large clumps were observed. The SD values obtained
from images were gradually decreased from 2000 mM to 200 mM (Figure 5B). However, 0.32–40 mM
NaCl did not affect the SD value, suggesting that Aβ42 aggregates were formed. The NaCl concentration
in sample A soy sauce is 16.2% (2.77 M). Because the EC50 of sample A is 0.065 ± 0.020 v/v%, it was
indicated that 1.8 mM NaCl is included. The NaCl concentration of the 0.4 v/v% and 0.04 v/v% solution
samples is 11 mM and 1.1 mM, respectively. Therefore, the NaCl in 0.065 v/v% (EC50 value) soy sauce
solution might not affect the formation of Aβ42 aggregates. In fact, as shown in Figure 3C, aggregation
was inhibited in samples A to J when NaCl was included at 0.4 v/v%. Especially, 0.04 v/v% of sample
A inhibited the aggregation formation. These results suggest that the Aβ42 aggregation inhibitory
activity by soy sauce was due to not NaCl but other components.
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system, he i fluence of NaCl concentration on the form tion of Aβ42 aggregates was examined.
At 2000 mM NaCl, Aβ42 and QDAβ were salted out. From their morphology, it is believed that
these solids were not Aβ42 aggregates. At 1000 mM, aggregates started to form. At 40 mM or less,
no significant effect was observed on the aggregates. From 40 to 0.32 mM, normal aggregates were
formed. Bars: 100 µm. (B) Ratio of SD value at each NaCl concentration. At 40 mM or less, the SD
value was not affected by NaCl concentration.
3.4. Influence of Heating and Dialysis Treatment on Aβ42 Aggregation Inhibitory Activity
As shown in Figure 3, among the 19 dressings, soy sauce showed the highest activity when the
MSHTS system was used. In fact, there are several types of soy sauce, which can be classified according
to the sterilization method, the composition of the raw materials, the color, and salt concentration of
the product. Among them, we focused on raw soy sauce that was not heat-sterilized. Since raw soy
sauce is sterilized by filtration, it has a feature that compounds produced during the fermentation
process and enzymes derived from microorganisms are not inactivated. Here, we evaluated Aβ42
aggregation inhibitory activity of raw soy sauce purchased from NIHON SYOYU KOGYO using the
MSHTS system. The Aβ42 aggregation inhibitory activity of raw soy sauce was 0.0045 ± 0.0015 v/v%
(Data not shown). This activity is about 15 times higher than that of soy sauce which showed the
highest activity among the 19 dressings. Therefore, it is likely that the difference in the aggregation
inhibitory activity of Aβ42 between soy sauce and raw soy sauce is caused by the raw material-derived
protein and the microorganism-derived enzyme, which are lost by heating.
To examine whether proteins and/or lo olecular weight compounds in soy sauce and raw
soy sauce affect Aβ42 aggregatio i ibitory activity, each sample was subjected to SDS-PAGE after
heat treatment (80 ◦C, 60 i ) / i l sis treatment and their band patterns were compared using
silver staining (Figure 6A). s SDS-P GE gel (lanes 1 and 5), the property and amount
of proteins in soy sauce and ra iff red. Bands were d tected at 15 and 25 kDa in both
samples while 30 and 100–200 kDa bands were detected only in raw soy sauce. Heat treatment did not
change the banding pattern of soy sauce, but reduced the intensity of the100–200 kDa band of raw soy
sauce (Figure 6A, from lanes 2 and 6). Dialysis treatment reduced the 10–15 and 25 kDa bands in both
samples (Figure 6A, lanes 3 and 7). Heat treatment after dialysis reduced the band at about 25 kDa in
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soy sauce less than the dialyzed sample, and reduced the bands at about 15, 25 and 100–200 kDa in
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Figure 6. Influence of heat a ial sis treat ent on Aβ42 aggregatio inhibitory activity of soy sauce
and raw soy sauce. (A) SDS-PAGE analysis demonstrated that heating and dialysis treatments changed
the band pattern of soy sauce and raw soy sauce. Lanes 1–4: soy sauce; lanes 5–8: raw soy sauce.
Lanes 1 and 5: control; lanes 2 and 6: heat treatment; lanes 3 and 7: dialysis treatment; lanes 4 and
8: dialysis and heat treatment. MW: molecular weight marker. (B) Fluorescence images of Aβ42
aggregates in each condition. Effect of heating and dialysis treatment on Aβ42 aggregation inhibition of
soy sauce and raw soy sauce. All images were captured using a conventional fluorescence microscope.
Bars: 100 µm. (C) Aβ42 aggregation inhibitory activity (EC50) of soy sauce and raw soy sauce after
heating and dialysis calculated by the MSHTS system. Whereas the activity of soy sauce was not
changed by heating, the EC50 of heated raw soy sauce was about 30 times higher than that of the
control sample, suggesting that the activity was greatly reduced. In both soy sauce and raw soy sauce,
EC50 was approximately double after dialysis.
Next, using the MSHTS system, we assessed whether heating and dialysis treatment would affect
the Aβ42 aggregation inhibitory activity of s y sauce and raw soy sauce (Figure 6B). Furthermore,
the dialyzed soy sauce and raw soy sauce were also heated and analyzed. As s own in Figure 6C,
the Aβ42 aggregation inhibitory activity of soy sauce was not changed by heating. This result was
consistent with the SDS-PAGE banding pattern (Figure 6A, lanes 1 and 2). In addition, the activity of
soy sauce decreased even after dialysis treatment, even more so when heat treatment followed dialysis.
The Aβ42 aggregation inhibitory activity of raw soy sauce was reduced by about 30 times or by about
half after heat treatment and dialysis, respectively. Dialysis treatment did not affect the 100–200 kDa
band that was reduced by heat treatment, i.e., the 100–200 kDa protein did not contribute to the
Aβ42 aggregation inhibitory activity of raw soy sauce. The heat treatment after dialysis decreased
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Aβ42 aggregation inhibitory activity by about 440 times, which was consistent with the SDS-PAGE
result in which many bands were reduced (Figure 6A, lane 8). These results suggest that the Aβ42
aggregation inhibitor found in soy sauce and raw soy sauce is a low molecular weight compound
that is removed by dialysis and a protein that is thermally denatured by heat treatment at 80 ◦C for
60 min. Since the Aβ42 aggregation inhibitory activity of raw soy sauce was greatly reduced after heat
treatment, the proteins found in raw soy sauce are considered to be particularly important for the
inhibition of Aβ42 aggregation.
In general, proteins and peptides are denatured by heating, then lose their physiological activity.
It is possible that the presence or absence of heat treatment in the fermentation process may be
involved in the physiological activity of dressings such as soy sauce, which contains Aβ42 aggregation
inhibitory activity. The main raw materials of soy sauce, soy, and wheat, are decomposed into amino
acids, peptides and saccharides in the manufacturing process. It is known that soybeans have many
physiologically active ingredients such as soy protein and isoflavone [25–27], so these physiologically
active ingredients are also present in soy sauce. Soy is widely applied to fermented foods such as
miso and natto, Japanese traditional foods. Actually, physiological activity has also been reported for
these foods. Miso extract suppresses Aβ-induced neuronal damage [16]. Genistein, one of isoflavone,
mitigated Aβ deposition and neuroinflammation in mice [28]. It was reported that natto peptide
exhibited antimicrobials effects and that nattokinase has amino residues playing a intramolecular
chaperone [24,29] Further, vitamin K2 (menaquinone-7), which is abundant in natto, is an important
factor in the synthesis of sphingolipids present in brain cell membranes that support cell signaling
function and structure formation [30–32]. We are currently investigating the active compound in raw
soy sauce using this analytical method. Soy sauce is used in many traditional dishes in Japan, and its
effectiveness against AD would be significant for the prevention of this disease.
4. Conclusions
In this work, we evaluated Aβ42 aggregation inhibitory activity of 19 commercial liquid dressings
using the MSHTS system. All tested dressings exhibited Aβ42 aggregation inhibitory activity,
suggesting that the MSHTS system can be applied to processed food containing various impurities.
Japanese traditional liquid dressings, soy sauce, exhibited the highest inhibitory activity. However,
these findings are limited to in vitro conditions. The physiological activity of the dressings should be
clarified through animal experiments, taking into account dynamics such as intestinal absorption and
metabolism, particularly the permeability of the blood-brain barrier. Although there is a strong demand
for functional food products that help maintain and improve brain function, it is not realistic to subject
all food products to animal testing. We are confident that we can progress quickly to a second screening
stage such as animal testing by using the MSHTS system as a first screening tool to discover food materials
with high Aβ42 aggregation inhibitory activity. Recently, we confirmed that aggregation of various
amyloid proteins Aβ42, tau, and α-synuclein could be visualized using nonlabelled QD and succeeded
in the evaluation of aggregation inhibitory activity of RA [33]. MSHTS system using nonspecific binding
of QD to amyloid proteins might bring speed and simplification of the screening of various foods
using various amyloids. Furthermore, we expected that the combination of our previously developed
automated-MSHTS system [21] and non-specific MSHTS system allows enormous, comprehensive
screening of foods, thereby creating the potential for new approaches to overcome AD.
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Aβ amyloid β
MSHTS system microliter-scale high-throughput screening system
PBS phosphate buffered saline
QD quantum dot
RA rosmarinic acid
SD value standard deviation value
SDS-PAGE SDS-polyacrylamide gel electrophoresis
TEM transmission electron microscope
ThT thioflavin T
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